1st Quarter - Report

PODESTA GROUP, INC. for BRISTOL-MYERS SQUIBB

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

LHHS appropriations Diabetes research issues Comparative effectiveness

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Copyright/Patent/Trademark CPT

H.R. 1260 Patent Reform Act of 2009 S. 515 Patent Reform Act of 2009

LobbyistCovered position, as disclosed
DANIELE BAIERLEIN —
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
COURTNEY HAGEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 515 (111th), H.R. 1260 (111th)

Medicare/Medicaid MMM

Medicare Issues

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

H.R. 1 American Recovery and Reinvestment Act of 2009 S. Con. Res. 13 H. Con. Res. 85

LobbyistCovered position, as disclosed
SHARON COHEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.Con.Res. 85 (111th), H.R. 1 (111th), S.Con.Res. 13 (111th)

Pharmacy PHA

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathyway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation/Drug Safety

LobbyistCovered position, as disclosed
PAUL BRATHWAITE Exec. Dir., Congressional Black Caucus
SHARON COHEN —
THOMAS B SPARKMAN Health Policy Intern, Senate HELP Committee

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S. 726 (111th), H.R. 1427 (111th), H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.